Coldstream Capital Management Inc. Grows Holdings in Cardinal Health, Inc. (NYSE:CAH)

Coldstream Capital Management Inc. raised its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 763.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,763 shares of the company's stock after acquiring an additional 22,780 shares during the quarter. Coldstream Capital Management Inc.'s holdings in Cardinal Health were worth $2,883,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Eastern Bank bought a new stake in Cardinal Health in the 3rd quarter valued at about $25,000. Cultivar Capital Inc. bought a new stake in shares of Cardinal Health in the second quarter valued at approximately $27,000. Frazier Financial Advisors LLC lifted its stake in shares of Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock valued at $28,000 after buying an additional 104 shares in the last quarter. Ashton Thomas Private Wealth LLC bought a new position in Cardinal Health in the 2nd quarter worth approximately $29,000. Finally, Hara Capital LLC purchased a new position in Cardinal Health in the 3rd quarter valued at approximately $31,000. 87.17% of the stock is owned by institutional investors.

Cardinal Health Price Performance

NYSE CAH traded down $3.26 on Wednesday, reaching $117.16. 745,802 shares of the company's stock traded hands, compared to its average volume of 2,094,213. The stock has a market cap of $28.35 billion, a PE ratio of 23.43, a P/E/G ratio of 1.53 and a beta of 0.61. Cardinal Health, Inc. has a 12 month low of $93.17 and a 12 month high of $126.23. The stock has a 50-day simple moving average of $116.71 and a 200 day simple moving average of $108.07.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The company had revenue of $52.28 billion for the quarter, compared to analysts' expectations of $50.90 billion. During the same quarter last year, the company earned $1.73 EPS. The firm's revenue was down 4.3% compared to the same quarter last year. As a group, analysts anticipate that Cardinal Health, Inc. will post 7.82 EPS for the current year.

Cardinal Health Cuts Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be issued a dividend of $0.5056 per share. The ex-dividend date is Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a yield of 1.73%. Cardinal Health's dividend payout ratio is currently 39.30%.

Analyst Ratings Changes

CAH has been the subject of a number of analyst reports. JPMorgan Chase & Co. raised their price target on Cardinal Health from $111.00 to $123.00 and gave the stock a "neutral" rating in a report on Wednesday, August 21st. Deutsche Bank Aktiengesellschaft lifted their target price on Cardinal Health from $119.00 to $124.00 and gave the company a "hold" rating in a report on Monday, November 4th. Argus increased their price target on shares of Cardinal Health from $115.00 to $125.00 and gave the stock a "buy" rating in a report on Wednesday, September 11th. Morgan Stanley boosted their price objective on shares of Cardinal Health from $119.00 to $127.00 and gave the company an "overweight" rating in a research note on Monday, November 4th. Finally, Wells Fargo & Company increased their target price on shares of Cardinal Health from $95.00 to $101.00 and gave the stock an "underweight" rating in a research note on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $124.58.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.